Alcon Labs Dealmaking Profile 2007 - Study the Top 50 Leading Biopharma Companies Based On 2006 Pharmaceutical Revenues.DUBLIN Dublin, city, Republic of Ireland Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River. , Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles. -- Research and Markets: Research and Markets (http://www.researchandmarkets.com/reports/c67854) has announced the addition of Alcon Labs Dealmaking Profile 2007 to their offering. Each Company Dealmaking Profile provides an in-depth in-depth adj. Detailed; thorough: an in-depth study. in-depth Adjective detailed or thorough: an in-depth analysis insight into the dealmaking activity and interests of one of the worlds leading biopharma companies. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company's business development objectives. The initial chapters of each report provide an orientation orientation, in architecture, the disposition of the parts of a building with reference to the points of the compass. From remote antiquity the traditional belief in the efficacy of religious ceremonials performed at dawn toward the rising sun has influenced the of bigpharma's dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 lists the top 50 leading biopharma companies based on 2006 pharmaceutical revenues. Chapter 3 analyses the most active dealmakers in 2005 and 2006 in M&A and partnering deals announced, whilst chapter 4 identifies the top deals of 2005-6 according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. reported deal size. The main body of each report is provided in chapter 5. An in-depth profile of the company provides everything required to assess the suitability of a company as a prospective partner. This includes a company overview, detailed analysis of the company's marketed and pipeline disease targets, partnering interests, partnering activity according to deal type, phase of development, therapy area. The profile also includes in-depth contact information for individuals within the business development function. The company profile is also provided with a comprehensive listing of contract documents available in the public domain. The listing is sorted by deal type - therefore co-promotion Co-promotion is a marketing practice where a company in addition to its own, uses another company's sales force to promote the same brand or range of brands. The term is frequently confused with Co-marketing. See also Marketing co-operation deals are listed separately to licensing, M&A and supply deals, and so on. Key benefits Company Dealmaking Profiles provide the user with the following key benefits: - Get ahead of your competitors COMPETITORS, French law. Persons who compete or aspire to the same office, rank or employment. As an English word in common use, it has a much wider application. Ferriere, Dict. de Dr. h.t. by understanding and contacting the best partners of choice - Identify prospective partner companies by analyzing their dealmaking activity and interests - Undertake initial due diligence Research; analysis; your homework. This term has caught on in all industries, because it sounds so "wired." Who would want to do analysis or research when they can do due diligence. See wired. to assess suitability of partner companies - Make direct contact with named business development executives within the company - Review actual contract agreements entered into by the company and its partner companies - Understand the key deal terms the company has agreed in previous deals Report scope Company Dealmaking Profiles are intended to provide business development executives, senior management and investors with decision-critical intelligence on a prospective partner's activities, interests and actual agreement contracts as signed by the company and its partners. Each Company Dealmaking Profile includes: - Company contact details - named contacts with their direct contact information - Subsidiary companies - Primary therapy areas - Business development contacts - Company description - Marketed therapeutic indications - Pipeline (phase I-III) therapeutic indications - Partnering interests - Partnering interests - therapeutic indications - Partnering frequency per annum Per annum Yearly. - 2000-2006 - Current partner companies (2005-6) - Recent deals 2005-2006 By deal type By stage of development By therapy area - Contract documents available online 2005-2006 - link direct to each document Each contract document is accessible through a link to an online version of the actual contract document as filed with the Securities Exchange Commission. Analyzing actual company agreements allows assessment of the following: - What is actually granted by the agreement to the partner company? - What exclusivity is granted? - What is the payment structure for the deal? - How are sales and payments audited? - What is the deal term? - How are the key terms of the agreement defined? - How are IPRs handled and owned? - Who is responsible for commercialization? - Who is responsible for development, supply, and manufacture? - How is confidentiality Restrictions on the accessibility and dissemination of information. Confidentiality is one of the six fundamental components of information security (see Parkerian Hexad). and publication managed? - How are disputes to be resolved? - Under what conditions can the deal be terminated ter·mi·nate v. ter·mi·nat·ed, ter·mi·nat·ing, ter·mi·nates v.tr. 1. To bring to an end or halt: ? - What happens when there is a change of ownership? - What sublicensing and subscontracting provisions have been agreed? - Which boilerplate A phrase or body of text used verbatim in different documents such as a signature at the end of a letter. Boilerplate is widely used in the legal profession as many paragraphs are used over and over in agreements with little modification or no modification. clauses does the company insist upon? - Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? - Which jurisdiction does the company insist upon for agreement law? Each report is comprised of approx. 40 pages + links to the online contract documents. Content Outline: Executive Summary Chapter 1 - Introduction Chapter 2 - Bigpharma - The Top 50 Chapter 3 - Most active bigpharma dealmakers Bigpharma M&A activity Bigpharma partnering Chapter 4 - Top bigpharma deals - 2000-6 Bigpharma M&A Bigpharma partnering Chapter 5 - Company Profile How to use company profiles Field definitions Company profile Company contact details Subsidiary companies Primary therapy areas Business development contacts Company description Marketed therapeutic indications Pipeline (phase I-III) therapeutic indications Partnering interests Partnering interests - therapeutic indications Partnering frequency per annum - 2000-2006 Current partner companies (2005-6) Recent deals 2005-2006 By deal type By stage of development By therapy area Contract documents available online - link direct to each document Chapter 6 - Resources Order Form - Reports Order Form - Company Dealmaking Profiles Order Form - Report Update Subscription Order Form - Contract Sets Order Form - Contract Documents Figures in report Figure 1: Bigpharma - top 50 by pharma Pharma may be an abbreviation for:
Figure 2: Leading Bigpharma M&A companies, 2005-6 Figure 3: Leading Bigpharma partnering companies, 2005-6 Figure 4: Leading M&A deals by value, 2005-6 Figure 5: Leading partnering deals by value, 2005-6 For more information visit http://www.researchandmarkets.com/reports/c67854. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion